Corvese Brian — SEC insider filings
SEC reporting owner CIK 1393207. 30 insider filings on record with FilingPulse; latest filed 2026-09-02.
Transaction summary — filings shown
Covers all 30 filings on record, filed 2020-12-21 to 2026-09-02. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 33.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| MiNK Therapeutics, Inc. (INKT) | Director | 20 | — | — | 21 |
| AGENUS INC (AGEN) | Director | 9 | — | — | 11 |
| Protagenic Therapeutics, Inc.\new (PTIX) | Director | 1 | — | — | 1 |
Insider filings — Corvese Brian
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-02 | 4 | MiNK Therapeutics, Inc. (INKT) | Grant/award (A): 1,633 @ $10.95 | EDGAR |
| 2026-08-11 | 4 | AGENUS INC (AGEN) | Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2026-06-02 | 4 | MiNK Therapeutics, Inc. (INKT) | Grant/award (A): 1,640 @ $10.90 · Grant/award (A): 1,444 @ $12.38 | EDGAR |
| 2026-04-28 | 4 | AGENUS INC (AGEN) | Grant/award (A): 210,000 (derivative) @ $0 | EDGAR |
| 2026-01-06 | 4 | MiNK Therapeutics, Inc. (INKT) | Grant/award (A): 5,395 (derivative) @ $0 | EDGAR |
| 2025-12-03 | 4 | MiNK Therapeutics, Inc. (INKT) | Grant/award (A): 1,612 @ $11.09 | EDGAR |
| 2025-09-11 | 4 | MiNK Therapeutics, Inc. (INKT) | Grant/award (A): 3,225 (derivative) @ $0 | EDGAR |
| 2025-09-03 | 4 | MiNK Therapeutics, Inc. (INKT) | Grant/award (A): 1,290 @ $13.86 | EDGAR |
| 2025-06-20 | 4 | AGENUS INC (AGEN) | Grant/award (A): 750 (derivative) @ $0 · Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2025-06-04 | 4 | MiNK Therapeutics, Inc. (INKT) | Grant/award (A): 2,494 @ $7.17 | EDGAR |
| 2025-03-05 | 4 | MiNK Therapeutics, Inc. (INKT) | Grant/award (A): 2,033 @ $8.79 | EDGAR |
| 2024-12-03 | 4 | MiNK Therapeutics, Inc. (INKT) | Grant/award (A): 24,400 @ $0.73 | EDGAR |
| 2024-09-05 | 4 | MiNK Therapeutics, Inc. (INKT) | Grant/award (A): 21,802 @ $0.82 | EDGAR |
| 2024-06-18 | 4 | AGENUS INC (AGEN) | Grant/award (A): 750 (derivative) @ $0 | EDGAR |
| 2024-06-05 | 4 | MiNK Therapeutics, Inc. (INKT) | Grant/award (A): 17,967 @ $0.99 | EDGAR |
| 2024-04-22 | 4 | AGENUS INC (AGEN) | Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2024-03-29 | 4 | Protagenic Therapeutics, Inc.\new (PTIX) | Grant/award (A): 43,750 (derivative) @ $1.74 | EDGAR |
| 2024-03-05 | 4 | MiNK Therapeutics, Inc. (INKT) | Grant/award (A): 18,816 @ $0.95 | EDGAR |
| 2023-12-05 | 4 | MiNK Therapeutics, Inc. (INKT) | Grant/award (A): 17,188 @ $1.04 | EDGAR |
| 2023-09-06 | 4 | MiNK Therapeutics, Inc. (INKT) | Grant/award (A): 12,244 @ $1.46 | EDGAR |
| 2023-06-16 | 4 | MiNK Therapeutics, Inc. (INKT) | Grant/award (A): 37,500 (derivative) @ $0 | EDGAR |
| 2023-06-02 | 4 | MiNK Therapeutics, Inc. (INKT) | Grant/award (A): 10,157 @ $1.76 | EDGAR |
| 2023-03-03 | 4 | MiNK Therapeutics, Inc. (INKT) | Grant/award (A): 8,553 @ $2.09 | EDGAR |
| 2022-12-05 | 4 | MiNK Therapeutics, Inc. (INKT) | Grant/award (A): 6,849 @ $2.61 | EDGAR |
| 2022-09-19 | 4 | MiNK Therapeutics, Inc. (INKT) | Grant/award (A): 13,646 @ $2.62 | EDGAR |
| 2022-03-11 | 4 | MiNK Therapeutics, Inc. (INKT) | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2022-02-08 | 4 | AGENUS INC (AGEN) | Grant/award (A): 150,000 (derivative) @ $0 | EDGAR |
| 2021-07-02 | 4 | AGENUS INC (AGEN) | Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2021-06-21 | 4 | AGENUS INC (AGEN) | Option exercise (M): 22,471 · Option exercise (M): 16,000 (derivative) | EDGAR |
| 2020-12-21 | 4 | AGENUS INC (AGEN) | Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-12-17 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1393207 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs